AIDS passive immunization (Wyeth-Ayerst)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAIDS passive immunization (Wyeth-Ayerst)

Drug Alias NameCD4-IgG (Wyeth)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionT-cell surface antigen CD4 inhibitorsImmunoglobulin G agonists

TargetsT-cell surface antigen CD4Immunoglobulin G

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesWyeth-Ayerst Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesWyeth-Ayerst Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A